Vanguard Capital Management
KMTS

Vanguard Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Vanguard Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9M Sell
1,175,525
-37,168
-3% -$778K ﹤0.01% 2223
2026
Q1 		$24.2M Buy
+1,212,693
New +$28.6M ﹤0.01% 2236

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Capital Management's KMTS Position: Q2 2026 in Review

Vanguard Capital Management reduced its Kestra Medical Technologies (KMTS) stake by 3.1% in Q2 2026, selling an estimated $778K and leaving 1,175,525 shares worth $29.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

Vanguard Capital Management first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Vanguard Capital Management held 1,175,525 shares of Kestra Medical Technologies worth $29.9M as of Q2 2026.
  • Vanguard Capital Management sold 37,168 Kestra Medical Technologies shares in Q2 2026, an estimated $778K.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2223 holding.
  • Vanguard Capital Management first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.